Jubilant Pharmova Ltd. - Research Center
530019 JUBLPHARMA Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 810.12 | 87.75 | 2,709.50 | 3,139.90 | 3,438.61 |
| Expenses | |||||
| Material consumed | 414.55 | - | 1,564.02 | 1,820.77 | 2,185.94 |
| Manufacturing expenses | 75.37 | 9.27 | 280.40 | 369.20 | 358.28 |
| Personnel expenses | 167.27 | 49.21 | 220.67 | 264.90 | 265.71 |
| Selling expenses | 1.43 | 0.33 | 0.26 | 4.20 | 4.53 |
| Adminstrative expenses | 148.26 | 35.72 | 217.08 | 309.93 | 303.28 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 806.89 | 94.54 | 2,282.44 | 2,769.00 | 3,117.74 |
| Operating profit | 3.23 | -6.79 | 427.06 | 370.90 | 320.88 |
| Other recurring income | 137.89 | 125.87 | 47.88 | 173.23 | 78.00 |
| Adjusted PBDIT | 141.12 | 119.08 | 474.94 | 544.14 | 398.88 |
| Financial expenses | 18.52 | 30.59 | 101.80 | 136.20 | 128.96 |
| Depreciation | 43.25 | 6.25 | 99.97 | 107.40 | 86.48 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 79.34 | 82.25 | 273.17 | 300.54 | 183.43 |
| Tax charges | 29.46 | 3.75 | 58.69 | -22.30 | 35.80 |
| Adjusted PAT | 49.88 | 78.50 | 214.48 | 322.84 | 147.63 |
| Non recurring items | -0.77 | 0.25 | -0.71 | -3.67 | -1.11 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 49.11 | 78.75 | 213.77 | 319.18 | 146.52 |
| Earnigs before appropriation | 1,203.14 | 1,233.67 | 1,367.03 | 1,306.10 | 1,098.22 |
| Equity dividend | 79.64 | 79.64 | - | 149.80 | 39.44 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | 1.52 | 8.35 |
| Retained earnings | 1,123.50 | 1,154.03 | 1,367.03 | 1,154.78 | 1,050.44 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis